Genedrive PLC (LON:GDR) insider Ian David Gilham purchased 51,250 shares of Genedrive stock in a transaction that occurred on Wednesday, July 17th. The shares were acquired at an average price of GBX 19 ($0.25) per share, for a total transaction of £9,737.50 ($12,723.77).

Shares of LON:GDR opened at GBX 17.50 ($0.23) on Friday. Genedrive PLC has a 1 year low of GBX 17 ($0.22) and a 1 year high of GBX 31.90 ($0.42). The stock has a market cap of $5.95 million and a P/E ratio of -0.60. The firm’s 50-day simple moving average is GBX 20.06.

Separately, Peel Hunt downgraded ASOS to a “hold” rating and reduced their price target for the company from GBX 4,000 ($52.27) to GBX 3,000 ($39.20) in a report on Thursday.

About Genedrive

genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. It operates through three divisions: Preclinical Research Services, Pharmacogenomic Services, and Diagnostics.

Read More: Book Value Per Share – BVPS

Receive News & Ratings for Genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genedrive and related companies with MarketBeat.com's FREE daily email newsletter.